Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825
Authors
Keywords
-
Journal
INFLAMMATION RESEARCH
Volume 72, Issue 10-11, Pages 2023-2036
Publisher
Springer Science and Business Media LLC
Online
2023-10-10
DOI
10.1007/s00011-023-01801-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The TLR/MyD88 signalling cascade in inflammation and gastric cancer: the immune regulatory network of Helicobacter pylori
- (2023) Meiqi Liu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Acute iron oxide nanoparticles exposure induced murine eosinophilic airway inflammation via TLR2 and TLR4 signaling
- (2022) Liang Yue et al. ENVIRONMENTAL TOXICOLOGY
- Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma
- (2022) Sara Rodriguez et al. Science Advances
- ST2825, a Small Molecule Inhibitor of MyD88, Suppresses NF-κB Activation and the ROS/NLRP3/Cleaved Caspase-1 Signaling Pathway to Attenuate Lipopolysaccharide-Stimulated Neuroinflammation
- (2022) Shan-Shan Zhang et al. MOLECULES
- TLR7 gain-of-function genetic variation causes human lupus
- (2022) Grant J. Brown et al. NATURE
- MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization
- (2022) Jie Zhang et al. Cell Death & Disease
- Inhalation of Salvianolic Acid B Prevents Fine Particulate Matter-Induced Acute Airway Inflammation and Oxidative Stress by Downregulating the LTR4/MyD88/NLRP3 Pathway
- (2022) Yan Guan et al. Oxidative Medicine and Cellular Longevity
- Inflammation Induced by Lipopolysaccharide and Palmitic Acid Increases Cholesterol Accumulation via Enhancing Myeloid Differentiation Factor 88 Expression in HepG2 Cells
- (2022) Junbin Chen et al. Pharmaceuticals
- Targeting IL-6 to prevent cardiac allograft rejection
- (2022) Cynthia L. Miller et al. AMERICAN JOURNAL OF TRANSPLANTATION
- MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages
- (2022) Allison M. Owen et al. Frontiers in Immunology
- Sleep deprivation aggravates brain injury after experimental subarachnoid hemorrhage via TLR4-MyD88 pathway
- (2021) Ye-Ping Xu et al. Aging-US
- MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization
- (2021) Qi Yuan et al. Cell Reports
- MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
- (2021) Kamal U. Saikh IMMUNOLOGIC RESEARCH
- Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies
- (2021) Anamaria Jurcau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MyD88: At the heart of inflammatory signaling and cardiovascular disease
- (2021) Abraham L. Bayer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- MyD88 in myofibroblasts regulates aerobic glycolysis‐driven hepatocarcinogenesis via ERK ‐dependent PKM2 nuclear relocalization and activation
- (2021) Qi Yuan et al. JOURNAL OF PATHOLOGY
- MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy‐dependent mechanism
- (2021) Ming Qi et al. Journal of Cachexia Sarcopenia and Muscle
- Discovery of a Novel MyD88 Inhibitor M20 and Its Protection Against Sepsis-Mediated Acute Lung Injury
- (2021) Jiali Song et al. Frontiers in Pharmacology
- Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients
- (2021) Sergio Ramirez-Perez et al. Frontiers in Pharmacology
- Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy
- (2020) Xu-yong Zheng et al. ACTA PHARMACOLOGICA SINICA
- TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro
- (2020) Zhimiao Zou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- TLR2/4 promotes PGE2 production to increase tissue damage in Escherichia coli-infected bovine endometrial explants via MyD88/p38 MAPK pathway
- (2020) Tingting Li et al. THERIOGENOLOGY
- Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor
- (2020) Sergio Ramírez-Pérez et al. MOLECULES
- Author Correction: A guiding map for inflammation
- (2020) Mihai G. Netea et al. NATURE IMMUNOLOGY
- In Systemic Sclerosis, a Unique Long Non Coding RNA Regulates Genes and Pathways Involved in the Three Main Features of the Disease (Vasculopathy, Fibrosis and Autoimmunity) and in Carcinogenesis
- (2019) Marzia Dolcino et al. Journal of Clinical Medicine
- Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation
- (2019) Young-Chan Kim et al. Nature Chemical Biology
- Inflammatory markers in systemic lupus erythematosus
- (2019) Martin Aringer JOURNAL OF AUTOIMMUNITY
- MYD88L265P Mutation in Lymphoid Malignancies
- (2018) Xinfang Yu et al. CANCER RESEARCH
- Hypoxia, oxidative stress and inflammation
- (2018) Trudy McGarry et al. FREE RADICAL BIOLOGY AND MEDICINE
- Polygonatum sibiricum polysaccharides play anti-cancer effect through TLR4-MAPK/NF-κB signaling pathways
- (2018) Tingting Long et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Peroxiredoxin 2 activates microglia by interacting with Toll-like receptor 4 after subarachnoid hemorrhage
- (2018) Yue Lu et al. Journal of Neuroinflammation
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- 1,4-β-d-Glucomannan from Dendrobium officinale Activates NF-кB via TLR4 to Regulate the Immune Response
- (2018) Yan-Ping Huang et al. MOLECULES
- Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats
- (2017) Na Wang et al. EXPERIMENTAL NEUROLOGY
- Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation
- (2017) Chao Li et al. TRANSPLANTATION
- Inhibition of myeloid differentiation primary response protein 88 provides neuroprotection in early brain injury following experimental subarachnoid hemorrhage
- (2017) Huiying Yan et al. Scientific Reports
- Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice
- (2016) Hua-Sheng Zhang et al. BRAIN RESEARCH
- Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia
- (2016) Xia Liu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Effect of ST2825 on the proliferation and apoptosis of human hepatocellular carcinoma cells
- (2016) Y. Deng et al. GENETICS AND MOLECULAR RESEARCH
- Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway
- (2016) Hong Yao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Polysaccharopeptide exerts immunoregulatory effects via MyD88-dependent signaling pathway
- (2016) Zifang Feng et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway
- (2016) Meng Qi et al. PHARMACOLOGICAL RESEARCH
- Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice
- (2016) Wen-Tao He et al. TRANSPLANT INTERNATIONAL
- Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension
- (2015) R Hernanz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Homeostasis, Inflammation, and Disease Susceptibility
- (2015) Maya E. Kotas et al. CELL
- Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70
- (2015) Meng Qi et al. PHARMACOLOGICAL RESEARCH
- Discovery of small molecule inhibitors of MyD88-dependent signaling pathways using a computational screen
- (2015) Mark A. Olson et al. Scientific Reports
- Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway
- (2015) Min Liu et al. Scientific Reports
- Mutational Analysis Identifies Residues Crucial for Homodimerization of Myeloid Differentiation Factor 88 (MyD88) and for Its Function in Immune Cells
- (2013) Maria Loiarro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Pharmacologic Inhibition of Myeloid Differentiation Factor 88 (MyD88) Prevents Left Ventricular Dilation and Hypertrophy After Experimental Acute Myocardial Infarction in the Mouse
- (2010) Benjamin W Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling
- (2010) Su-Chang Lin et al. NATURE
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients
- (2010) Federica Capolunghi et al. RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started